Rapid Drug Susceptibility Testing for Isoniazid and Rifampicin by Reverse Hybridization Assay

Young-Kil PARK; Hee-Kyoung YU; Sung-Weon RYU; Gill-Han BAI.
Tuberculosis and Respiratory Diseases ; : 440-448, 2003.
Artículo en Ko | WPRIM | ID: wpr-83750

Documentos relacionados

  1. No evidence of increased risk of acquired rifampin resistance.
  2. How Flu-like Syndromes Contribute to Termination of Weekly Rifapentine-Based TB Preventive Therapy Is Still Poorly Predictable.
  3. Detection of Isoniazid and Rifampin Resistance in Mycobacterium tuberculosis Clinical Isolates from Sputum Samples by High-Resolution Melting Analysis.
  4. Pharmacokinetics of rifampicin, isoniazid & pyrazinamide during daily & intermittent dosing: A preliminary study.
  5. A Shorter Regimen for Rifampin-Resistant Tuberculosis.
  6. A Shorter Regimen for Rifampin-Resistant Tuberculosis.
  7. A Shorter Regimen for Rifampin-Resistant Tuberculosis. Reply.
  8. [Evaluation of a high-intensity fluorescent fluorophage method for diagnosis of drug-resistance in tuberculosis].
  9. Iterative Methylation Leads to 3-Methylchuangxinmycin Production in <i>Actinoplanes tsinanensis</i> CPCC 200056.
  10. Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection.